CFZ533

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for CFZ533, covering 2018-05-21 to 2025-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome [Phase 2]